CN Stock MarketDetailed Quotes

Teyi Pharmaceutical Group (002728)

Watchlist
  • 10.70
  • -0.26-2.37%
Market Closed Apr 17 15:00 CST
5.49BMarket Cap67.30P/E (TTM)

Teyi Pharmaceutical Group (002728) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Chinese patent medicine494.51M53.49%
Chemical preparation357.59M38.68%
Chemical raw material65.42M7.08%
Chemical products and others7.01M0.76%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry908.06M98.22%
Pharmaceutical commerce9.46M1.02%
Chemical products and others7.01M0.76%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
South China486.68M52.64%
East China157.95M17.08%
Northeast China75.93M8.21%
Southwest62.04M6.71%
North China52.97M5.73%
Central China52.12M5.64%
Northwest35.96M3.89%
Overseas869.17K0.09%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More